Who are Bayer's key investors?

Key investors in Bayer include Bank of America, Bill & Melinda Gates Foundation, Temasek Holdings, and Rabobank Brasil.

How many employees does Bayer have?

As of Sat, 25 Apr 2026, Bayer has approximately 10,001+ employees employees.

How much website traffic does Bayer receive?

Bayer receives about 1M monthly website visits in the latest Datakart source snapshot. This helps benchmark market attention, demand generation, and digital reach.

Is Bayer currently hiring?

Bayer has 477 open roles in the latest source snapshot. Open job volume can indicate team expansion, budget movement, and active buying needs by department.

What technologies does Bayer use?

Bayer's detected technology footprint includes Neo4J, Greenhouse, Oracle Database, Jira, Ubuntu, Aruba Wireless. The full profile lists additional verified technologies when available.

Company profile

Chemical Manufacturing

Bayer - Company Intelligence Profile

Industry: Chemical Manufacturing | Founded: not publicly disclosed | HQ: Leverkusen, Germany

Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for Bayer to help teams evaluate the account with useful business context.

Public company

Bayer

bayer.com

Employees

97.9K

Monthly visits

Open roles

477

Search volume

33.1K

View intelligence Start free trial

Company Snapshot

At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses.

Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world.

Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint

N/A

Founded

97.9K

Employee count

Monthly website visits

477

Open roles

Company Snapshot Details

Legal name: Bayer AG

Headquarters: Leverkusen, North Rhine-Westphalia, Germany

Industry: Chemical Manufacturing

Sub-sector: Chemical Manufacturing

Website: https://www.bayer.com

YoY headcount growth: not publicly disclosed

Company stage: Public Company

Last updated: Sat, 25 Apr 2026

Company intelligence

Business signals that help qualify Bayer

This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.

Source snapshot

Last refreshed 2026-04-25 | 33K search volume | Domain bayer.com

Annual revenue

$48.6B

Reported annual revenue from the source dataset when available.

Quarterly revenue

EUR 9.7B

Standalone quarterly revenue field from the source dataset.

Monthly visits

Latest monthly visits value available from the source dataset.

Global web rank

#47,870

Lower rank values indicate stronger web visibility in the source dataset.

Employees

97.9K

Latest employees value available from the source dataset.

Employee reviews

11.8K

Latest employee reviews value available from the source dataset.

-109 monthly (-18.6%)

Hiring demand

477

Open roles reveal which teams may be expanding and where vendor demand can emerge. For Bayer, this signal is based on the latest available source snapshot.

+497 monthly (+0.5%)

Headcount momentum

97.9K

Recent employee count movement helps qualify growth, contraction, and operational scale. For Bayer, this signal is based on the latest available source snapshot.

+71.6K monthly (+1.0%)

Audience growth

6.9M

LinkedIn follower movement is a useful proxy for employer brand, market attention, and hiring reach. For Bayer, this signal is based on the latest available source snapshot.

-43.3K monthly (-4.0%)

Web demand

Website traffic movement helps benchmark customer interest and go-to-market momentum. For Bayer, this signal is based on the latest available source snapshot.

0 quarterly

Employee sentiment

3.9

Employee review movement can surface internal confidence, culture stability, and retention risk. For Bayer, this signal is based on the latest available source snapshot.

Identity atlas

Bayer identity, aliases, ownership, and taxonomy

This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.

Company descriptions

All available company description fields from the source dataset.

Company descriptiondescription

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world. Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint

Enriched descriptionDescription Enriched

Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture. They develop solutions that improve lives and protect the planet.

LinkedIn followers

6.9M

Latest linkedin followers value available from the source dataset.

Owler followers

18.5K

Latest owler followers value available from the source dataset.

Technologies detected

1.1K

Latest technologies detected value available from the source dataset.

Ownership and corporate structure

Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Public Company

type

Ownership status

Public

Ownership Status

Public company

Yes

Is Public

Aliases and domain variants

Company name aliases, website aliases, and canonical domain signals.

Company alias

bayer

Company Name Alias

Company alias

bayer ag

Company Name Alias

Website alias

https://www.bayer.com

Website Alias

Website alias

https://www.bayer.com/

Website Alias

Website alias

https://www.bayer.com/en/career

Website Alias

Website alias

https://www.bayer.com/en

Website Alias

Canonical website

https://www.bayer.com

website

Website domain

bayer.com

Website Domain

Unique website

Yes

Unique Website

Unique domain

Yes

Unique Domain

Expired domain

Expired Domain

LinkedIn shorthand

bayer

Canonical LinkedIn Shorthand Name

Source ID

1893

Source ID

UUID

3C85E9XGD7TQ47R42BB9CAXHYF

uuid

Industry classification codes

SIC, NAICS, industry, and keyword classification signals.

Industry

Chemical Manufacturing

industry

Categories and keywords

['healthcare and agriculture', 'health', 'manufacturing-industrial', 'agritech', 'biotech', 'conglomerates', 'drug-development', 'life-sciences', 'nutrition', 'pharma', 'agriculture', 'healthcare', 'solutions', 'innovation', 'global', 'biotechnology', 'chemical', 'health care', 'life science', 'pharmaceutical', 'science for better', 'pharmaceuticals', 'consumer health', 'crop science', 'life sciences', 'research', 'sustainability', 'digital farming', 'food security']

Categories And Keywords

Social follower counts

Follower counts available across LinkedIn, Twitter, and Owler.

LinkedIn followers

6.9M

Followers Count LinkedIn

Owler followers

18.5K

Followers Count Owler

Company locations

Known company locations and office addresses.

Primary location

Kaiser-Wilhelm-Allee; Leverkusen, North Rhine-Westphalia 51373, DE

Office location

Avenida Tamanaco; Caracas, Miranda, VE

Office location

100 Bayer Blvd; Whippany, NJ 07981, US

Office location

Calle Francisco Alonso, 7; Alcala de Henares, Community of Madrid 28806, ES

Office location

Achter Clarenburg 25; Utrecht, Utrecht 3511 JH, NL

Office location

South Oak Way; Reading, England RG2 0, GB

Office location

Avenida de las Americas 80C-57; Bogota, Bogota, D.C. 110851, CO

Office location

27 Wrench Road; Isando; Kempton Park, Gauteng 1600, ZA

Social profiles

Official and source-linked social profiles.

Website

https://www.bayer.com

https://www.linkedin.com/company/bayer

Crunchbase

https://www.crunchbase.com/organization/bayer-ag-germany

Facebook

https://www.facebook.com/bayersuomi

Twitter / X

https://www.twitter.com/bayer

Instagram

https://www.instagram.com/bayerofficial

YouTube

https://www.youtube.com/@bayerglobal

Company contact points

Public company-level contact points available in the source dataset.

info@bayer.com

Phone

1925-1945

Phone

1881-1914

Phone

1974-1988

Financial intelligence

Bayer revenue, funding, IPO, and acquisition history

Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.

Annual revenue

$48.6B

Reported annual revenue from the source dataset when available.

Quarterly revenue

EUR 9.7B

Standalone quarterly revenue field from the source dataset.

Revenue range

$10B+

Reported annual revenue band from the source dataset.

Total disclosed funding

$4.5B

Sum of disclosed funding round amounts available in the source dataset.

Funding rounds

Number of funding rounds captured in the source dataset.

Acquisitions captured

117

Number of acquisition records captured across the available source columns.

Revenue signals

Annual, quarterly, and range-based revenue signals available in the source dataset.

Source 5

$48.6B

Annual revenue

Source 1EUR 46.6B

Source 4$10B+

Standalone quarterly revenueEUR 9.7B

IPO and stock listing

IPO date, share price, exchange tickers, and public market identifiers.

IPO date

2009-10-02

IPO Date

Stock tickerBAYN.DE

Stock tickerBAYN

Latest closing priceEUR 25.55

Latest market capEUR 25.1B

Ownership and corporate structure

Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Public Company

type

Ownership status

Public

Ownership Status

Public company

Yes

Is Public

Income statement rows

Income statement rows with revenue and profitability metrics where available.

Q3, 2025

Primary value

Revenue: EUR 9.7B

Additional metrics

Gross profit: EUR 6.7B; EBITDA: EUR 476M; EBIT: EUR -529M; Net income: EUR -959M; Operating expense: EUR 6.2B; Gross margin: 69.1%; EBITDA margin: 4.9%

Q2, 2025

Primary value

Revenue: EUR 10.7B

Additional metrics

Gross profit: EUR 7.3B; EBITDA: EUR 260M; EBIT: EUR -12M; Net income: EUR -190M; Operating expense: EUR 7.1B; Gross margin: 68.4%; EBITDA margin: 2.4%

Q1, 2025

Primary value

Revenue: EUR 13.7B

Additional metrics

Gross profit: EUR 9.5B; EBITDA: EUR 3.5B; EBIT: EUR 2.3B; Net income: EUR 1.3B; Operating expense: EUR 6B; Gross margin: 69.1%; EBITDA margin: 25.4%

FY, 2024

Fiscal Year

Primary value

Revenue: EUR 46.6B

Additional metrics

Gross profit: EUR 35.8B; EBITDA: EUR 8.8B; EBIT: EUR -211M; Net income: EUR -2.5B; Operating expense: EUR 26.9B; Gross margin: 76.8%; EBITDA margin: 18.9%

Q3, 2024

Primary value

Revenue: EUR 10B

Additional metrics

Gross profit: EUR 10B; EBITDA: EUR 906M; EBIT: EUR -3.9B; Net income: EUR -4.2B; Operating expense: EUR 9B; Gross margin: 100.0%; EBITDA margin: 9.1%

Q2, 2024

Primary value

Revenue: EUR 11.1B

Additional metrics

Gross profit: EUR 7.8B; EBITDA: EUR 1.6B; EBIT: EUR 490M; Net income: EUR -26M; Operating expense: EUR 6.1B; Gross margin: 70.1%; EBITDA margin: 14.6%

Q1, 2024

Primary value

Revenue: EUR 13.8B

Additional metrics

Gross profit: EUR 9.7B; EBITDA: EUR 4.2B; EBIT: EUR 3.1B; Net income: EUR 2B; Operating expense: EUR 5.5B; Gross margin: 70.4%; EBITDA margin: 30.4%

FY, 2023

Fiscal Year

Primary value

Revenue: EUR 47.6B

Additional metrics

Gross profit: EUR 42.1B; EBITDA: EUR 13.1B; EBIT: EUR 441M; Net income: EUR -2.9B; Operating expense: EUR 28.8B; Gross margin: 88.4%; EBITDA margin: 27.5%

Q3, 2023

Primary value

Revenue: EUR 10.3B

Additional metrics

Gross profit: EUR 10.6B; EBITDA: EUR 1.3B; EBIT: EUR -3.6B; Net income: EUR -4.6B; Operating expense: EUR 9.2B; Gross margin: 1.0%; EBITDA margin: 12.6%

Q2, 2023

Primary value

Revenue: EUR 11B

Additional metrics

Gross profit: EUR 10.2B; EBITDA: EUR 2.3B; EBIT: EUR -1B; Net income: EUR -1.9B; Operating expense: EUR 7.9B; Gross margin: 92.6%; EBITDA margin: 20.7%

Q1, 2023

Primary value

Revenue: EUR 14.4B

Additional metrics

Gross profit: EUR 10.4B; EBITDA: EUR 4.3B; EBIT: EUR 2.9B; Net income: EUR 2.2B; Operating expense: EUR 6.1B; Gross margin: 72.2%; EBITDA margin: 29.8%

FY, 2022

Fiscal Year

Primary value

Revenue: EUR 50.7B

Additional metrics

Gross profit: EUR 39.9B; EBITDA: EUR 13.4B; EBIT: EUR 7.2B; Net income: EUR 4.2B; Operating expense: EUR 26.2B; Gross margin: 78.7%; EBITDA margin: 26.5%

Period	Primary value	Additional metrics
Q3, 2025 Q3	Revenue: EUR 9.7B	Gross profit: EUR 6.7B; EBITDA: EUR 476M; EBIT: EUR -529M; Net income: EUR -959M; Operating expense: EUR 6.2B; Gross margin: 69.1%; EBITDA margin: 4.9%
Q2, 2025 Q2	Revenue: EUR 10.7B	Gross profit: EUR 7.3B; EBITDA: EUR 260M; EBIT: EUR -12M; Net income: EUR -190M; Operating expense: EUR 7.1B; Gross margin: 68.4%; EBITDA margin: 2.4%
Q1, 2025 Q1	Revenue: EUR 13.7B	Gross profit: EUR 9.5B; EBITDA: EUR 3.5B; EBIT: EUR 2.3B; Net income: EUR 1.3B; Operating expense: EUR 6B; Gross margin: 69.1%; EBITDA margin: 25.4%
FY, 2024 Fiscal Year	Revenue: EUR 46.6B	Gross profit: EUR 35.8B; EBITDA: EUR 8.8B; EBIT: EUR -211M; Net income: EUR -2.5B; Operating expense: EUR 26.9B; Gross margin: 76.8%; EBITDA margin: 18.9%
Q3, 2024 Q3	Revenue: EUR 10B	Gross profit: EUR 10B; EBITDA: EUR 906M; EBIT: EUR -3.9B; Net income: EUR -4.2B; Operating expense: EUR 9B; Gross margin: 100.0%; EBITDA margin: 9.1%
Q2, 2024 Q2	Revenue: EUR 11.1B	Gross profit: EUR 7.8B; EBITDA: EUR 1.6B; EBIT: EUR 490M; Net income: EUR -26M; Operating expense: EUR 6.1B; Gross margin: 70.1%; EBITDA margin: 14.6%
Q1, 2024 Q1	Revenue: EUR 13.8B	Gross profit: EUR 9.7B; EBITDA: EUR 4.2B; EBIT: EUR 3.1B; Net income: EUR 2B; Operating expense: EUR 5.5B; Gross margin: 70.4%; EBITDA margin: 30.4%
FY, 2023 Fiscal Year	Revenue: EUR 47.6B	Gross profit: EUR 42.1B; EBITDA: EUR 13.1B; EBIT: EUR 441M; Net income: EUR -2.9B; Operating expense: EUR 28.8B; Gross margin: 88.4%; EBITDA margin: 27.5%
Q3, 2023 Q3	Revenue: EUR 10.3B	Gross profit: EUR 10.6B; EBITDA: EUR 1.3B; EBIT: EUR -3.6B; Net income: EUR -4.6B; Operating expense: EUR 9.2B; Gross margin: 1.0%; EBITDA margin: 12.6%
Q2, 2023 Q2	Revenue: EUR 11B	Gross profit: EUR 10.2B; EBITDA: EUR 2.3B; EBIT: EUR -1B; Net income: EUR -1.9B; Operating expense: EUR 7.9B; Gross margin: 92.6%; EBITDA margin: 20.7%
Q1, 2023 Q1	Revenue: EUR 14.4B	Gross profit: EUR 10.4B; EBITDA: EUR 4.3B; EBIT: EUR 2.9B; Net income: EUR 2.2B; Operating expense: EUR 6.1B; Gross margin: 72.2%; EBITDA margin: 29.8%
FY, 2022 Fiscal Year	Revenue: EUR 50.7B	Gross profit: EUR 39.9B; EBITDA: EUR 13.4B; EBIT: EUR 7.2B; Net income: EUR 4.2B; Operating expense: EUR 26.2B; Gross margin: 78.7%; EBITDA margin: 26.5%

Funding rounds

Funding history and recent round context.

Post-IPO Debt

$192.3M

2026-01-01 | Rabobank Brasil

Post-IPO Debt

$331.5M

2025-10-26

Post-IPO Debt

CHF 265M

2025-09-01

Grant

$12M

2022-11-08 | Bill & Melinda Gates Foundation

Post-IPO Equity

$3.7B

2018-04-17 | Temasek Holdings

Post-IPO Equity

1996-12-01

Post-IPO Debt

Bank of America

Acquisitions and corporate activity

Acquisitions and corporate activity captured in the source dataset.

Attralus, Inc's Pan-Amyloid Radiotracers

Acquisition

2026-01-01 | Acquisition List Source 5

Camelina Germplasm, Intellectual Property, and Materials

Acquisition

2025-01-01 | Acquisition List Source 5

Cara Care

Acquisition

2024-12-11 | Acquisition List Source 2

Natsana GmbH

Acquisition

2024-07-02 | Acquisition List Source 1

Bayer Zydus Pharma Private Limited

Acquisition

2024-05-01 | Acquisition List Source 5

NIAB’s Strawberry Assets

Acquisition

2023-09-01 | Acquisition List Source 5

Malling Fruits

Acquisition

2023-09-01 | Acquisition List Source 5

Blackford Analysis

Acquisition

2023-02-13 | Acquisition List Source 1

Combyne Ag

Acquisition

2023-01-19 | Acquisition List Source 1

Blackford Analysis

Acquisition

2023-01-18 | Acquisition List Source 2

Blackford Analysis Ltd.

Acquisition

2023-01-01 | Acquisition List Source 5

Targenomix

Acquisition

2022-11-10 | Acquisition List Source 1

Targenomix GmbH

Acquisition

2022-11-01 | Acquisition List Source 5

Covercress

EUR 111M

2022-08-01 | Acquisition List Source 1

Vividion Therapeutics

EUR 1.3B

2021-08-19 | Acquisition List Source 1

Vividion Therapeutics

$1.5B

2021-08-05 | Acquisition List Source 2

Noria Therapeutics

Acquisition

2021-06-03 | Acquisition List Source 2

Noria Therapeutics

Acquisition

2021-06-02 | Acquisition List Source 1

PSMA Therapeutics

Acquisition

2021-06-02 | Acquisition List Source 1

Asklepios BioPharmaceutical

EUR 3.4B

2020-12-01 | Acquisition List Source 1

Noho Health

Acquisition

2020-11-16 | Acquisition List Source 1

Asklepios BioPharmaceutical

$2B

2020-10-26 | Acquisition List Source 2

KaNDy Therapeutics

EUR 376M

2020-09-09 | Acquisition List Source 1

Care/of

$225M

2020-08-31 | Acquisition List Source 2

KaNDy Therapeutics

$450M

2020-08-11 | Acquisition List Source 2

BlueRock Therapeutics

$1B

2019-08-08 | Acquisition List Source 1

Monsanto

EUR 48B

2018-06-07 | Acquisition List Source 1

Monsanto

$62.5B

2016-05-23 | Acquisition List Source 2

Zoner.ag

Acquisition

2015-02-15 | Acquisition List Source 1

Dihon Pharmaceutical

EUR 460M

2014-11-05 | Acquisition List Source 1

Merck-Consumer Care (MCC)

$14.2B

2014-10-01 | Acquisition List Source 1

Algeta

$2.9B

2013-12-19 | Acquisition List Source 1

AgraQuest, Inc.

$425M

2012-07-01 | Acquisition List Source 1

Artificial Muscle Inc

Acquisition

2010-03-11 | Acquisition List Source 1

Icon Genetics

Acquisition

2006-02-13 | Acquisition List Source 1

Zeptosens

Acquisition

2005-03-09 | Acquisition List Source 1

Tavros Therapeutics

Acquisition

Acquisition List Source 1

Zydus Pharma Private

Acquisition

Acquisition List Source 1

Bayer Australia Limited

Acquisition

Acquisition List Source 1

Nimbus Ceres, LLC

Acquisition

Acquisition List Source 1

Bayer Nigeria Limited

Acquisition

Acquisition List Source 1

Bayer New AU M3650 LLC

Acquisition

Acquisition List Source 1

Bayer New MX M3640 LLC

Acquisition

Acquisition List Source 1

KaNDy Therapeutics Limited

Acquisition

Acquisition List Source 1

Monsanto Agriculture Nigeria Limited

Acquisition

Acquisition List Source 1

7WIRE VENTURES FUND II SIDE FUND, L.P.

Acquisition

Acquisition List Source 1

Bayer Holding (Thailand) Co., Ltd.

Acquisition

Acquisition List Source 1

Bayer S.A. (Ecuador)

Acquisition

Acquisition List Source 1

Bayer (Cambodia) Co., Ltd.

Acquisition

Acquisition List Source 1

Bayer CropScience Pty Limited

Acquisition

Acquisition List Source 1

Mahyco Monsanto Biotech (India) Private Limited

Acquisition

Acquisition List Source 1

Bayer Samson I LLC

Acquisition

Acquisition List Source 1

Monsanto Company

Acquisition

Acquisition List Source 1

Monsanto Operations B.V.

Acquisition

Acquisition List Source 1

Bayer US Holding LP

Acquisition

Acquisition List Source 1

GP Grenzach Produktions GmbH

Acquisition

Acquisition List Source 1

Bayer Taiwan Company Ltd.

Acquisition

Acquisition List Source 1

Bayer Altersversorgung GmbH

Acquisition

Acquisition List Source 1

Bayer Direct Services GmbH

Acquisition

Acquisition List Source 1

AskBio GmbH

Acquisition

Acquisition List Source 1

Bayer S.A. (Colombia)

Acquisition

Acquisition List Source 1

Brainvectis SAS

Acquisition

Acquisition List Source 1

TecArena+ GmbH

Acquisition

Acquisition List Source 1

Bayer CropScience K.K.

Acquisition

Acquisition List Source 1

The Climate Services Company, LLC

Acquisition

Acquisition List Source 1

UAB Bayer

Acquisition

Acquisition List Source 1

Bayer CropScience Limited (India)

Acquisition

Acquisition List Source 1

Bayer Chemicals GmbH

Acquisition

Acquisition List Source 1

Bayer Zambia Limited

Acquisition

Acquisition List Source 1

Bayer New TH M1763 LLC

Acquisition

Acquisition List Source 1

BlueRock Therapeutics GP LLC

Acquisition

Acquisition List Source 1

Monsanto (Malaysia) SDN. BHD.

Acquisition

Acquisition List Source 1

Bayer CropScience Inc. (Canada)

Acquisition

Acquisition List Source 1

Monsanto El Salvador S.A. de C.V.

Acquisition

Acquisition List Source 1

Bayer LLC Saudi Arabia

Acquisition

Acquisition List Source 1

CropScience NewCo de Mexico, S.A. de C.V.

Acquisition

Acquisition List Source 1

Bayer S.A. (Morocco)

Acquisition

Acquisition List Source 1

Monsanto Thailand Limited

Acquisition

Acquisition List Source 1

Bayer New CA M5015 LLC

Acquisition

Acquisition List Source 1

Bayer Public Limited Company

Acquisition

Acquisition List Source 1

Bayer Production II LLC

Acquisition

Acquisition List Source 1

Monsanto Vegetable Seed Holding LLC

Acquisition

Acquisition List Source 1

SIA Bayer

Acquisition

Acquisition List Source 1

MiraLAX, LLC

Acquisition

Acquisition List Source 1

Bayer Zimbabwe (Private) Limited

Acquisition

Acquisition List Source 1

Bayer SA

Acquisition

Acquisition List Source 1

Monsanto Puerto Rico Ag Products LLC

Acquisition

Acquisition List Source 1

Bayer S.A. (Guatemala)

Acquisition

Acquisition List Source 1

Bayer d.o.o. (Croatia)

Acquisition

Acquisition List Source 1

Monsanto Technology LLC

Acquisition

Acquisition List Source 1

CoverCress Inc.

Acquisition

Acquisition List Source 1

Bayer US Finance LLC

Acquisition

Acquisition List Source 1

Bayer s.r.o.

Acquisition

Acquisition List Source 1

Hornbeck Seed Company, Inc.

Acquisition

Acquisition List Source 1

Bayer New MA M3130 LLC

Acquisition

Acquisition List Source 1

The Climate Insurance Agency LLC

Acquisition

Acquisition List Source 1

Bayer Medical Care B.V.

Acquisition

Acquisition List Source 1

Bayer Great Lakes Production Co., LLC

Acquisition

Acquisition List Source 1

Schering Berlin Inc.

Acquisition

Acquisition List Source 1

Lilienthalstraße Nr. 4 GmbH

Acquisition

Acquisition List Source 1

Bayer-Handelsgesellschaft mit beschränkter Haftung

Acquisition

Acquisition List Source 1

Olympia Corp.

Acquisition

Acquisition List Source 1

BUS C.V.

Acquisition

Acquisition List Source 1

Hans und Berthold Finkelstein Stiftung gGmbH

Acquisition

Acquisition List Source 1

Monsanto Seeds LLC

Acquisition

Acquisition List Source 1

Joyn Bio LLC

Acquisition

Acquisition List Source 1

Bayer HealthCare US Funding LLC

Acquisition

Acquisition List Source 1

Bayer Northern Production Co., LLC

Acquisition

Acquisition List Source 1

Biagro S.A.

Acquisition

Acquisition List Source 1

Bayer CropScience Holdings Pty Ltd

Acquisition

Acquisition List Source 1

Bayer Elets Production LLC

Acquisition

Acquisition List Source 1

Sechste Bayer Real Estate VV GmbH & Co. KG

Acquisition

Acquisition List Source 1

Zweite K-W-A Beteiligungsgesellschaft mbH

Acquisition

Acquisition List Source 1

Athenix Corp.

Acquisition

Acquisition List Source 1

Bayer CropScience Ltd. (Republic Korea)

Acquisition

Acquisition List Source 1

BlueRock Therapeutics

Acquisition

Acquisition List Source 2

PSMA Therapeutics

Acquisition

Acquisition List Source 2

Audience analytics

Web visibility, demand, and topics

Use these signals to understand discoverability, demand quality, search interest, and audience fit.

Monthly visits

Latest monthly visits value available from the source dataset.

Global web rank

#47,870

Lower rank values indicate stronger web visibility in the source dataset.

Bounce rate

54.0%

Latest bounce rate value available from the source dataset.

Pages per visit

3.45

Latest pages per visit value available from the source dataset.

Average visit duration

2m 6s

Latest average visit duration value available from the source dataset.

Estimated monthly page views

3.6M

Derived estimate calculated as monthly visits multiplied by pages per visit.

Website visits

Website visits trend from the latest source snapshots.

LinkedIn followers

LinkedIn followers trend from the latest source snapshots.

Website visits by country

United States25.48

Germany18.27

India5.35

Mexico3.5

Canada2.9

Employees, hiring, attrition, and compensation

This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.

Employees

97.9K

Latest employees value available from the source dataset.

Inferred employees

54K

Latest inferred employees value available from the source dataset.

Open roles

477

Latest open roles value available from the source dataset.

Departures

Latest departures value available from the source dataset.

Employee attrition rate

0.0%

Latest employee attrition rate value available from the source dataset.

Hiring intensity

4.9 roles / 1K employees

Derived signal showing open roles normalized by employee count.

Employee headcount

Employee headcount trend from the latest source snapshots.

Inferred employees

Inferred employees trend from the latest source snapshots.

Open job postings

Open job postings trend from the latest source snapshots.

Employee attrition rate

Employee attrition rate trend from the latest source snapshots.

Employee count by department

Other Department9K

Operations7.4K

Sales7.1K

Technical5.3K

Research4.8K

Medical3.6K

Marketing3.1K

Employee count by seniority

Specialist23K

Manager11.2K

Other Management11.2K

Senior5.1K

Head3K

Director1.3K

Intern1K

Employee count by region

Northern America12.8K

Latin America11.4K

Western Europe10.1K

Southern Asia5K

Southern Europe3.1K

Eastern Europe2.4K

South Eastern Asia2.4K

Top employee countries

United States11.9K

Germany6.6K

Brazil6K

India4.4K

Mexico1.8K

Spain1.7K

France1.6K

Active job openings

Selected open roles that reveal current hiring demand.

E&I Construction Engineer

Open role

3936702701

医药代表-广阔市场-韶关

Open role

4091610349

Kraftwerker/Kesselwärter (m/f/d) im Schichtbetrieb

Open role

4202603800

Medical Specialist

Open role

4202608106

Regional Procurement Mgr-Tolling

Open role

4203160911

Ausbildung zum Landwirt (alle Geschlechter)

Open role

4205035294

Internships

Open role

4205040024

Senior Fullstack Software Engineer

Open role

4217820343

Showing 8 of 18 available records.

Where employees came from

Common previous employers visible in employee profile movement.

Monsanto Company

9.2K employee movements

Internal profile link

Novartis

1.6K employee movements

Internal profile link

Sanofi

1.5K employee movements

Internal profile link

Pfizer

1.4K employee movements

Internal profile link

Roche

1.2K employee movements

Internal profile link

Syngenta

1.1K employee movements

Internal profile link

GSK

1K employee movements

Internal profile link

AstraZeneca

879 employee movements

Internal profile link

Showing 8 of 9 available records.

Where employees go next

Common next employers visible in employee profile movement.

BASF

2.5K employee movements

Internal profile link

Covestro

1.6K employee movements

Internal profile link

Novartis

1.4K employee movements

Internal profile link

Sanofi

1.4K employee movements

Internal profile link

Pfizer

1.3K employee movements

Internal profile link

Syngenta

1.3K employee movements

Internal profile link

AstraZeneca

1.1K employee movements

Internal profile link

Roche

989 employee movements

Internal profile link

Showing 8 of 10 available records.

Base pay benchmarks

Selected base salary benchmarks from the source dataset.

Wissenschaftler

EUR $84.9K

Annual | Updated 2024-09-21

Consulting Intern

EUR $21.3K

Monthly | Updated 2024-09-21

Lab Head

EUR $90K

Annual | Updated 2024-09-20

Químico Farmacéutico

MXN $130.5K

Monthly | Updated 2024-09-18

Analista De Laboratório Pleno

BRL $130.5K

Monthly | Updated 2024-09-18

Consultor De Recursos Humanos (RH)

BRL $130.5K

Monthly | Updated 2024-09-18

Estagiário Administrativo

BRL $130.5K

Monthly | Updated 2024-09-18

Especialista Em Farmacovigilância

BRL $130.5K

Monthly | Updated 2024-09-18

Showing 8 of 10 available records.

Additional pay benchmarks

Selected bonus and additional compensation benchmarks.

Lab Head

Cash Bonus $12.3K; Stock Bonus $5.7K; Profit Sharing $1.1K

Annual | Updated 2024-09-20

Químico Farmacéutico

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Advogado Tributário Pleno

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Analisa de laboratório

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Analista Contábil Júnior

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Analista De Operações Pleno

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Analista De Campanha Sênior

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Analista De Assuntos Regulatórios

Cash Bonus $14.1K

Monthly | Updated 2024-09-18

Showing 8 of 10 available records.

Total compensation benchmarks

Selected total compensation benchmarks from the source dataset.

Wissenschaftler

EUR $84.9K

Annual | Updated 2024-09-21

Consulting Intern

EUR $21.3K

Monthly | Updated 2024-09-21

Lab Head

EUR $91.5K

Annual | Updated 2024-09-20

Supervisor/Coordenador Planejamento Financeiro

BRL $144.6K

Monthly | Updated 2024-09-18

Supervisor De Produção

BRL $144.6K

Monthly | Updated 2024-09-18

Délégué Médical

EUR $144.6K

Annual | Updated 2024-09-18

Advogado Tributário Pleno

BRL $144.6K

Monthly | Updated 2024-09-18

Analisa de laboratório

BRL $144.6K

Monthly | Updated 2024-09-18

Showing 8 of 10 available records.

Product and reputation

Product readiness, customer proof, and employee sentiment

Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.

Employee reviews

11.8K

Latest employee reviews value available from the source dataset.

Employee rating

3.9

Latest review score available from the source dataset.

Employee review distribution

Score 43.4K

Score 53.4K

Score 31.6K

Score 2530

Score 1350

Employee review score breakdown

Diversity Inclusion4.1

Work Life Balance4

Compensation Benefits3.9

Culture Values3.9

Career Opportunities3.4

Senior Management3.3

Recommend75.0%

Product availability Q&A

Buyer-facing product availability signals in question-and-answer format.

Is pricing information available?

No. The source snapshot does not list pricing information for this company.

Source availability signal

Is a free trial listed?

No. The source snapshot does not list a free trial for this company.

Source availability signal

Can buyers request a demo?

No. The source snapshot does not list a demo motion for this company.

Source availability signal

Is the product downloadable?

Yes. The source snapshot lists downloadable software for this company.

Source availability signal

Are mobile apps listed?

No. The source snapshot does not list mobile apps for this company.

Source availability signal

Is public documentation listed?

No. The source snapshot does not list public documentation for this company.

Source availability signal

Are online reviews listed?

No. The source snapshot does not list online reviews for this company.

Source availability signal

Company graph

Technology, leadership, competitors, funding, and corporate activity

These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.

Verified technologies

Detected tools and systems verified in the source dataset.

Neo4J

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Greenhouse

Verified technology

Last verified 2026-05-04 | First seen 2024-04-04

Oracle Database

Verified technology

Last verified 2026-05-04 | First seen 2024-05-20

Jira

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Ubuntu

Verified technology

Last verified 2026-05-04 | First seen 2024-04-04

Aruba Wireless

Verified technology

Last verified 2026-05-04 | First seen 2026-02-01

Datavision

Verified technology

Last verified 2026-05-04 | First seen 2026-04-20

Tibco

Verified technology

Last verified 2026-05-04 | First seen 2024-04-04

Showing 8 of 24 available records.

Market alternatives and competitors

Comparable companies surfaced by the source dataset.

Shionogi

Comparable company

Market alternative

Johnson & Johnson

Comparable company

Market alternative

Astrazeneca

Comparable company

Market alternative

Pfizer

Comparable company

Market alternative

Novartis

Comparable company

Market alternative

Astellas Pharma

Comparable company

Market alternative

Gsk

Comparable company

Market alternative

Roche

Comparable company

Market alternative

Showing 8 of 12 available records.

Leadership and senior operators

Senior employees and operators visible in the source dataset.

Estelle Pelloux

Human Resources Business Partner

Thomas Struble

Director, Machine Learning Research

Scott Essner

Global Market Development Field Innovation Data Scientist Lead

Gustavo Trindade

Product Supply Innovation Director

Jörn Werwath

Head Of Quality

Mariana David

HR Site Head

Thomas Burger 🧬

Digital Lead Pharma Research

Jack Wu

South Regional Traning Head

Showing 8 of 12 available records.

Recent executive arrivals

Recent leadership and senior employee arrival signals.

Saikat Das

Chemical Development Lead

Nov 2025

Stacey Karlovic

Owner

Nov 2025

Ted Chen

Associate Director Regional Marketing/Thought Leader Liaison

Mar 2026

Kayla Brugman

Business Execution Lead

Mar 2026

Brittany Riggio

Regional Associate Director - Health Systems and Population Health

Mar 2026

Justine Gizzi

National Operations Lead, Cardiovascular and Women’s Health, US

Mar 2026

Jason Dempsey Pianucci

Technical Product Management Leader

Mar 2026

Leire Pérez Ibarbia

Formulation Development Leader

Mar 2026

Recent executive departures

Recent leadership and senior employee departure signals.

Jan Uhlemann

Head of Strategy & Operations

Mar 2026

Mike Martinez

Lead Data Scientist

Mar 2026

Maggie Martin

Omnichannel Customer Marketing Lead for Walmart

Mar 2026

Kayla Brugman

Marketing Solutions Lead

Mar 2026

Benjamin Cosculluela Giral

Head of Tax & Treasury

Mar 2026

Julia Duncan

Global Director, Development Finance

Mar 2026

Shawna Jones

Associate Director, Radiology Portfolio Marketing

Mar 2026

Christoph Boss

Subcluster Lead Medicinal Chemistry CVRI @ Bayer

Mar 2026

Company locations

Known company locations and office addresses.

Primary location

Kaiser-Wilhelm-Allee; Leverkusen, North Rhine-Westphalia 51373, DE

Office location

Avenida Tamanaco; Caracas, Miranda, VE

Office location

100 Bayer Blvd; Whippany, NJ 07981, US

Office location

Calle Francisco Alonso, 7; Alcala de Henares, Community of Madrid 28806, ES

Office location

Achter Clarenburg 25; Utrecht, Utrecht 3511 JH, NL

Office location

South Oak Way; Reading, England RG2 0, GB

Office location

Avenida de las Americas 80C-57; Bogota, Bogota, D.C. 110851, CO

Office location

27 Wrench Road; Isando; Kempton Park, Gauteng 1600, ZA

Recent company updates

Recent company update signals from the source dataset.

A lot of progress was achieved, but there is still a lot to do. Today, at our Annual Stockholders Meeting, ou…

358 reactions; 6 comments

2026-04-24 | A lot of progress was achieved, but there is still a lot to do. Today, at our Annual Stockholders Meeting, our CEO Bill Anderson shared that we expect to enter 2027 stronger than we've been in a long time. #HealthForA…

At Hannover Messe 2026 this week, we demonstrate what energy transition could look like from the ground up, a…

232 reactions; 5 comments

2026-04-23 | At Hannover Messe 2026 this week, we demonstrate what energy transition could look like from the ground up, and Brazil's agricultural sector serves as a prime example: It has been going through a tremendous transformati…

Donovan Viales, Senior Recruiter at Bayer, recommends a simple habit: read the job description closely, selec…

270 reactions; 10 comments

2026-04-23 | Donovan Viales, Senior Recruiter at Bayer, recommends a simple habit: read the job description closely, select a relevant part of your background, and describe the outcome in the same terms the role uses. This helps you…

Independent voices help us do better for people and planet. 🌍 That’s why Bayer has established the Sustainab…

98 reactions; 3 comments

2026-04-22 | Independent voices help us do better for people and planet. 🌍 That’s why Bayer has established the Sustainability Council – an independent, external group of experts that advises our Board of Management and closely wor…

This month on the SSA Ubuntu Blog, we spotlight Antoinette (Annie) Van Rooyen Customer Engagement Specialist…

47 reactions; 7 comments

2026-04-22 | This month on the SSA Ubuntu Blog, we spotlight Antoinette (Annie) Van Rooyen Customer Engagement Specialist in our Pharmaceuticals Division and 2025 Representative of the Year award recipient. 🌟 Antoinette shares how…

82 million people supported in 2025. For Ayu, it meant support during pregnancy — and a healthier start for…

121 reactions; 7 comments

2026-04-21 | 82 million people supported in 2025. For Ayu, it meant support during pregnancy — and a healthier start for her daughter. Because when access improves, health doesn’t just change for one person. It strengthens commun…

Industry classification codes

SIC, NAICS, industry, and keyword classification signals.

Industry

Chemical Manufacturing

industry

Categories and keywords

Categories And Keywords

Public market signal

Bayer stock snapshot

TradingView market widget for FRA:BAYN.

FRA:BAYN

Bayer FAQs

Company profile

Want verified contact data for Bayer?

Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at Bayer and 1,700+ other companies.

Start your free trial Directory